Neuropharmacological profile of FrPbAII, purified from the venom of the social spider Parawixia bistriata (Araneae, Araneidae), in Wistar rats

Life Sciences

Volumn 80, Issue 6, 2007, Pages 566-572

  Gelfuso, Erica Aparecida ^a   Cunha, Alexandra Olimpio Siqueira ^a   Mortari, Marcia Renata ^a   Liberato, Jose Luiz ^a   Paraventi, Karina Haddad ^a   Beleboni, Rene Oliveira ^b   Coutinho Netto, Joaquim ^a   Lopes, Norberto Peporine ^c   dos Santos, Wagner Ferreira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

^c Organic Chemistry Laboratory   (Brazil)

Author keywords

Anticonvulsants; FrPbAII; GABA uptake; Spider venom compounds

Indexed keywords

2 AMINO 5 UREIDOPENTANAMIDE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; DIAZEPAM; KAINIC ACID; NIPECOTIC ACID; PENTETRAZOLE; PICROTOXIN; PILOCARPINE; SPIDER VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG PURIFICATION; LATENT PERIOD; LOCOMOTION; LOW DRUG DOSE; MALE; MAZE TEST; NEUROPHARMACOLOGY; NEUROTOXICITY; NONHUMAN; PARAMETER; PARAWIXIA BISTRIATA; RAT; ROTAROD TEST; SEIZURE; SPIDER; TOXICITY TESTING; WISTAR RAT;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; MALE; MAZE LEARNING; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, GABA; SEIZURES; SPIDER VENOMS; SPIDERS; UREA;

ANIMALIA; ARANEAE; ARANEIDAE; RATTUS NORVEGICUS;

EID: 33845980631     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.10.002     Document Type: Article

References (31)

1. Andersen K.E., Lau J., Lundt B.F., Petersen H., Hunsfeldt P.O., Suzdak P.D., and Swedberg M.D.B. Synthesis of novel GABA uptake inhibitors. Part 6: preparation and evaluation of N-W asymmetrically substituted nipecotic acid derivatives. Bioorganic and Medicinal Chemistry 9 (2001) 2773-2785
2. Beleboni R.O., Carolino R.O.G., Pizzo A.B., Castellan-Baldan L., Coutinho-Netto J., Santos W.F., and Coimbra N.C. Pharmacological and biochemical aspects of GABAergic neurotransmission: pathological and neuropsycobiological relationships. Cellular and Molecular Neurobiology 24 6 (2004) 707-728
3. Beleboni R.O., Pizzo A.B., Fontana A.C.K., Carolino R.O.G., Coutinho-Netto J., and Santos W.F. Spider and wasp neurotoxins: pharmacological and biochemical aspects. European Journal of Pharmacology 17 (2004) 1-17
4. Beleboni R.O., Guizzo R., Fontana A.C.K., Pizzo A.B., Carolino R.O.G., Gobbo-Neto L., Peporine N.L., Coutinho-Netto J., and Santos W.F. Neurochemical characterization of a neuroprotective compound from Parawixia bistriata spider venom that inhibits synaptosomal uptake of GABA and glycine. Molecular Pharmacology 69 6 (2006) 1998-2006
5. Cairrão M.A.R., Ribeiro A.M., Pizzo A.B., Fontana A.C.K., Beleboni R.O., Coutinho-Neto J., Miranda A., and Santos W.F. P. bistriata and S. raptoria venoms: inhibition of GABA uptake and convulsant effect. Pharmaceutical Biology 40 (2002) 472-477
6. Croucher M.J., Meldrum B.S., and Krogsgaard-Larsen P. Anticonvulsant activity of GABA uptake inhibitors and their prodrugs following central or systemic administration. European Journal of Pharmacology 89 3-4 (1983) 217-228
7. Dalby N.O. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology 39 12 (2000) 2399-2407
8. Dalby N.O. Inhibition of y-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures. European Journal of Pharmacology 479 (2003) 127-137
9. Dalby N.O., Thomsen C., Fink-Jensen A., Lundbeck J., Sokilde B., Man C.M., Sorensen P.O., and Meldrum B. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1. Epilepsy Research 28 1 (1997) 51-61
10. Finney D.J. Probit Analysis. 3rd. Edition (1971), Cambridge University Press 368
11. Gadea A., and Lopez-Colome A.M. Glial transporters for glutamate, glycine and GABA. II: GABA transporters. Journal of Neuroscience Research 63 (2001) 461-468
12. Genton P. When antiepileptic drugs aggravate epilepsy. Brain and Development 22 (2000) 75-80
13. Jallon P. The problem of intractability: the continuing need for new medical therapies in epilepsy. Epilepsia 38 Suppl. 9 (1997) S37-S42
14. Krogsgaard-Larsen P., and Johnston G.A. Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds. Journal of Neurochemistry 25 6 (1975) 797-802
15. Kwan P., Graeme J.S., and Brodie M.J. The mechanisms of commonly used antiepileptic drugs. Pharmacology and Therapeutics 90 (2001) 21-34
16. Lamberty Y., and Klingaard H. Consequences of pentylenotetrazole-induced kindling on spational memory and emotional responding in the rat. Epilepsy and Behavior 1 (2000) 256-261
17. LaRoche S.M., and Helmers S.I. The new antiepileptic drugs: scientific review. JAMA 291 5 (2004) 605-614
18. Löscher W. New visions in the pharmacology of anticonvulsion. Review. European Journal of Pharmacology 342 (1998) 1-13
19. Meldrum B. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia 38 Suppl. 9 (1997) S7-S15
20. Mellor I.R., and Usherwood P.N.R. Targeting ionotropic receptors with polyamine-containing toxins. Toxicon 43 (2004) 493-508
21. Moldrich R.X., Chapman A.G., De Sarro G., and Meldrum B.S. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. European Journal of Pharmacology 22;476 1-2 (2003) 3-16
22. Morris R.G.M., Garrud P., Rawlins J.N.P., and O'Keefe J.O. Place navigation impaired in rats with hippocampal lesions. Nature 297 24 (1982) 681-683
23. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. Second Edition (1986), Academic Press, Inc., Sidney
24. Pinel J.P., and Rovner L.I. Experimental epileptogenesis; kindling-induced epilepsy in rats. Experimental Neurology 58 2 (1978) 190-202
25. Raza M., Shaheen F., Choudhary M.I., Sombati S., Rafiq A., Suria A., Rahman A.U., and DeLorenzo R.J. Anticonvulsant activities of ethanolic extract and aqueous fraction isolated from Delphinium denudatum. Journal of Ethnopharmacology 78 (2001) 73-78
26. Schmitt U., and Hiemke C. Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze. Behavioural Pharmacology 10 2 (1999) 131-137
27. Schousboe A., Sarup A., Larsson O.M., and White H.S. GABA transporters as drug targets for modulation of GABAergic activity. Biochemical Pharmacology 68 8 (2004) 1557-1563
28. Speller J., and Westby G.W.M. Bicuculline-induced circling from the rat superior colliculus is blocked by GABA microinjection into deep cerebellar nuclei. Experimental Brain Research 110 (1996) 425-434
29. Suzdak P.D., and Jensen J.A. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 36 (1995) 612-626
30. Villetti G., Bregola G., Bassani F., Bergamaschi M., Rondelli I., Pietra C., and Simonato M. Preclinical evaluation of CHF3381 as a novel antiepileptic agent. Neuropharmacology 40 (2001) 866-878
31. White H.S., Sarup A., Bolvig T., Kristensen A.S., Petersen G., and Nelson N. Correlation between anticonvulsant activity and inhibitory action on glial GABA uptake of the highly selective mouse Gat1 inhibitor 3-Hydroxy-4-Amino-4,5,6,7-Tetrahydro-12-Benzisoxazole (Exo-Thpo) and its N-Alkylated analogs. Journal of Pharmacology and Experimental Therapeutics 302 (2002) 636-644